| Clinical outcomes of a genomic screening program for actionable genetic conditions AH Buchanan, HL Kirchner, MLB Schwartz, MA Kelly, T Schmidlen, ... Genetics in Medicine 22 (11), 1874-1882, 2020 | 118 | 2020 |
| Maternal and infant health care costs related to preeclampsia J Hao, D Hassen, Q Hao, J Graham, MJ Paglia, J Brown, M Cooper, ... Obstetrics & Gynecology 134 (6), 1227-1233, 2019 | 77 | 2019 |
| Cost-effectiveness of population-wide genomic screening for hereditary breast and ovarian cancer in the United States GF Guzauskas, S Garbett, Z Zhou, SJ Spencer, HS Smith, J Hao, ... JAMA network open 3 (10), e2022874-e2022874, 2020 | 73 | 2020 |
| Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis S Deng, Y Xi, H Wang, J Hao, X Niu, W Li, Y Tao, G Chen Cellular Immunology 265 (2), 105-10, 2010 | 73 | 2010 |
| Patterns of multiple Emergency Department visits: Do primary care physicians matter? DD Maeng, J Hao, JB Bulger The Permanente Journal 21 (16), 2017 | 54 | 2017 |
| Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in … AK Rahm, D Cragun, JE Hunter, MM Epstein, J Lowery, CY Lu, ... BMC health services research 18, 1-11, 2018 | 48 | 2018 |
| Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals J Hao, R Rodriguez-Monguio, Seoane-Vazquez, Enrique Plos One 10 (10), e0140708, 2015 | 44 | 2015 |
| Population genomic screening for three common hereditary conditions: a cost-effectiveness analysis GF Guzauskas, S Garbett, Z Zhou, JS Schildcrout, JA Graves, MS Williams, ... Annals of Internal Medicine 176 (5), 585-595, 2023 | 40 | 2023 |
| The Therapeutic Effect of Vasoactive Intestinal Peptide on Experimental Arthritis is Associated with CD4+CD25+ T Regulatory Cells G Chen, J Hao, W Wang, W Li Scandinavian Journal of Immunology 68 (6), 572-8, 2008 | 38 | 2008 |
| A cost-effectiveness analysis of an adenocarcinoma risk prediction multi-biomarker assay for patients with Barrett’s esophagus J Hao, R Critchley-Thorne, DL Diehl, SR Snyder ClinicoEconomics and Outcomes Research, 623-635, 2019 | 23 | 2019 |
| Is universal HLA‐B*15:02 screening a cost‐effective option in an ethnically diverse population? A case study of Malaysia HY Chong, Z Mohamed, LL Tan, DBC Wu, FH Shabaruddin, M Dahlui, ... British Journal of Dermatology 177 (4), 1102-1112, 2017 | 23 | 2017 |
| Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program J Hao, D Hassen, K Manickam, MF Murray, DN Hartzel, Y Hu, K Liu, ... Journal of Personalized Medicine 10 (1), 7, 2020 | 20 | 2020 |
| Measuring Adherence and Outcomes in the Treatment of Patients With Multiple Sclerosis J Hao, J Pitcavage, JB Jones, C Hoegerl, J Graham The Journal of the American Osteopathic Association 117 (12), 737-747, 2017 | 20 | 2017 |
| Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States SJ Spencer, LK Jones, GF Guzauskas, J Hao, MS Williams, JF Peterson, ... Journal of clinical lipidology 16 (5), 667-675, 2022 | 17 | 2022 |
| Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States GF Guzauskas, S Jiang, S Garbett, Z Zhou, SJ Spencer, SR Snyder, ... Genetics in Medicine 24 (5), 1017-1026, 2022 | 17 | 2022 |
| Generic cost-effectiveness models: a proof of concept of a tool for informed decision-making for public health precision medicine SR Snyder, J Hao, LH Cavallari, Z Geng, A Elsey, JA Johnson, ... Public health genomics 21 (5-6), 217-227, 2019 | 15 | 2019 |
| Economic evaluation of universal Lynch syndrome screening protocols among newly diagnosed patients with colorectal cancer J Hao, D Hassen, JM Gudgeon, SR Snyder, H Hampel, MS Williams, ... Journal of Personalized Medicine 11 (12), 1284, 2021 | 13 | 2021 |
| Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model R Yuliwulandari, JG Shin, E Kristin, FD Suyatna, ID Prahasto, K Prayuni, ... The pharmacogenomics journal 21 (4), 476-483, 2021 | 12 | 2021 |
| Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost DD Maeng, J Graham, M Bogart, J Hao, EA Wright ClinicoEconomics and Outcomes Research 10, 551—562, 2018 | 11 | 2018 |
| Thyroidectomy outcomes in patients identified with RET pathogenic variants through a population genomic screening program PFA Pichardo, RN Hellums, J Hao, JM Savatt, D Hassen, PK Pellitteri, ... JAMA Otolaryngology–Head & Neck Surgery 149 (3), 195-202, 2023 | 10 | 2023 |
Susan R. SnyderAssociate Professor, Georgia State University School of Public HealthVerified email at gsu.edu
